These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2808309)

  • 1. Chlorprothixene-induced hypouricemia: a biologic indicator of drug compliance.
    Shalev A; Hermesh H; Munitz H; Birger M
    J Clin Psychiatry; 1989 Nov; 50(11):424-7. PubMed ID: 2808309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypouricemic effect of zuclopenthixol: a potential marker of drug compliance?
    Bloch M; Gur E; Shalev AY
    Psychopharmacology (Berl); 1992; 109(3):377-8. PubMed ID: 1365639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypouricemic effect of chlorprothixene.
    Shalev A; Hermesh H; Munitz H
    Clin Pharmacol Ther; 1987 Nov; 42(5):562-6. PubMed ID: 3315391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 5. Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.
    Karbwang J; Fungladda W; Pickard CE; Shires S; Hay A; Feely M
    Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):67-73. PubMed ID: 9763725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged hypouricemia associated with acute chlorprothixene ingestion.
    Weinshilboum RM; Goldstein JL; Kelley WN
    Arthritis Rheum; 1975; 18(6 Suppl):739-41. PubMed ID: 1201117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of psychotic drive disorders].
    Langner E
    Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic renal hypouricemia.
    Shichiri M; Iwamoto H; Shiigai T
    Arch Intern Med; 1987 Feb; 147(2):225-8. PubMed ID: 3813739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of chlorprothixene and its metabolites in breast milk.
    Matheson I; Evang A; Overø KF; Syversen G
    Eur J Clin Pharmacol; 1984; 27(5):611-3. PubMed ID: 6519168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorprothixene drops in clinical practice.
    Pazdírek S; Zapletálek M; Preiningerová O; Hametová M; Hanus H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(4):471-9. PubMed ID: 7010519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Why psychotic patients are not drug compliant?].
    Bordenave-Gabriel C; Giraud-Baro E; De Beauchamp I; Bougerol T; Calop J
    Encephale; 2003; 29(3 Pt 1):213-22. PubMed ID: 12876545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular hypouricemia and calcium urolithiasis.
    Kotake T; Miura N; Ito H
    Scanning Microsc; 1993 Mar; 7(1):417-21. PubMed ID: 8316811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol or hydrochlorothiazide in patients with hypertension aged 60-75 years. With special reference to assessment of compliance. Hunter Hypertension Research Group.
    Med J Aust; 1986 Nov; 145(10):521-3. PubMed ID: 2877386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects.
    Don BR
    Clin Nephrol; 2001 Jan; 55(1):45-52. PubMed ID: 11200867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Chlorprothixen and thioridazine in maintenance therapy of longterm hospital psychotics.
    Vojtĕchovský M; Král J
    Act Nerv Super (Praha); 1975; 17(4):212-3. PubMed ID: 1221759
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia.
    Kaneko K; Fujimori S; Itoh H; Nakayama Y; Oyama H; Kanbayashi T; Miyashita H; Akaoka I
    J Rheumatol; 1988 Feb; 15(2):325-30. PubMed ID: 3361540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.